BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:53 PM EDT
341.00quote price arrow down-0.35 (-0.10%)
Volume
21,933
Close
341.35quote price arrow up+2.34 (+0.69%)
Volume
2,386,410
52 week range
58.81 - 464.00
Loading...
  • Open344.77
  • Day High349.93
  • Day Low337.04
  • Prev Close339.01
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low58.81
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap82.784B
  • Shares Out242.52M
  • 10 Day Average Volume3.60M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change318.73

KEY STATS

  • Open344.77
  • Day High349.93
  • Day Low337.04
  • Prev Close339.01
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low58.81
  • 52 Week Low Date09/24/20
  • Market Cap82.784B
  • Shares Out242.52M
  • 10 Day Average Volume3.60M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change318.73

RATIOS/PROFITABILITY

  • EPS (TTM)19.38
  • P/E (TTM)17.61
  • Fwd P/E (NTM)7.99
  • EBITDA (MRQ)6.999B
  • ROE (MRQ)133.85%
  • Revenue (MRQ)9.11B
  • Gross Margin (MRQ)85.01%
  • Net Margin (MRQ)52.41%
  • Debt To Equity (MRQ)21.87%

EVENTS

  • Earnings Date11/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO8:2908:29
Dr. Fauci on boosters, breakthrough cases and CDC data

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
434.76-3.24-0.74%
REGN
Regeneron Pharmaceuticals Inc
646.95+6.06+0.95%
BIIB
Biogen Inc
295.54-2.95-0.99%
MRNA
Moderna Inc
434.04+10.71+2.53%
GRFS
Grifols SA
15.60+0.19+1.23%